Action CSLLY CSL LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Société CSL Limited OTC Markets

Actions

CSLLY

US12637N2045

Produits pharmaceutiques

Marché Fermé - OTC Markets
Autres places de cotation
 21:59:33 17/05/2024 		Varia. 5j. Varia. 1 janv.
94,01 USD -1,34% Graphique intraday de CSL Limited +2,47% -3,25%
17/05 Les actions australiennes se replient, les banques, les technologies et les soins de santé étant à la traîne RE
16/05 Les actions australiennes augmentent grâce aux données sur l'inflation américaine qui renforcent les espoirs de réduction des taux d'intérêt RE

Métier

CSL Limited est une société de biotechnologie basée en Australie. Ses domaines de prédilection sont les maladies rares et graves, les vaccins antigrippaux, les carences en fer et la néphrologie. Les segments de la société comprennent CSL Behring, CSL Seqirus et CSL Vifor. Le segment CSL Behring fabrique, commercialise et distribue des produits plasmatiques, des thérapies géniques et des recombinants. Le segment CSL Seqirus fabrique, commercialise et distribue principalement des produits liés à la grippe et fournit des services pandémiques aux gouvernements. Le segment CSL Vifor fabrique, commercialise et distribue des produits dans les domaines thérapeutiques de la carence en fer et de la néphrologie. CSL Plasma exploite des réseaux de collecte de plasma, avec plus de 325 centres de collecte de plasma aux États-Unis, en Europe et en Chine. La société est présente en Australie, aux États-Unis, en Allemagne, au Royaume-Uni, en Suisse et en Chine. Ses produits comprennent Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam et d'autres.

Nombre d'employés: 32 065

Ventes par activité

AUD en Millions2022Poids2023Poids Delta
CSL Behring
69,8 %
11 857 81,4 % 13 811 69,8 % +16,48%
CSL Seqirus
15,3 %
2 708 18,6 % 3 019 15,3 % +11,52%
CSL Vifor
14,9 %
- - 2 957 14,9 % -

Ventes par région

AUD en Millions2022Poids2023Poids Delta
United States
49,3 %
7 065 48,5 % 9 757 49,3 % +38,10%
Rest of World
21,4 %
2 776 19,1 % 4 236 21,4 % +52,59%
Australia
7,9 %
1 409 9,7 % 1 554 7,9 % +10,23%
Germany
6,5 %
1 077 7,4 % 1 292 6,5 % +19,93%
China
5,9 %
1 027 7,0 % 1 158 5,9 % +12,79%
United Kingdom
5,4 %
822 5,6 % 1 066 5,4 % +29,68%
Switzerland
3,7 %
388 2,7 % 725 3,7 % +86,90%

Dirigeants

Dirigeants TitreAgeDepuis
Paul McKenzie CEO
 Chief Executive Officer 58 01/06/19
Joy Carolyn Linton DFI
 Director of Finance/CFO 59 01/10/20
Mark Hill CTO
 Chief Tech/Sci/R&D Officer 62 01/10/20
William Mezzanotte CTO
 Chief Tech/Sci/R&D Officer 66 01/10/18
Andrew Nash CTO
 Chief Tech/Sci/R&D Officer - 01/11/06
Andrew Cuthbertson BRD
 Director/Board Member 70 01/03/97
Mark Dehring IRC
 Investor Relations Contact - -
Kate Priestman PRN
 Corporate Officer/Principal - 11/09/23
Ken Lim PRN
 Corporate Officer/Principal 50 01/01/13
Bill Campbell PRN
 Corporate Officer/Principal 64 01/01/14

Administrateurs

Administrateurs TitreAgeDepuis
Carolyn Hewson BRD
 Director/Board Member 69 09/12/19
Brian McNamee PSD
 President 68 01/07/90
Alison Watkins BRD
 Director/Board Member 61 19/08/21
Andrew Cuthbertson BRD
 Director/Board Member 70 01/03/97
Megan Clark BRD
 Director/Board Member 66 16/02/16
Marie McDonald BRD
 Director/Board Member 68 14/08/13
Sam Lewis BRD
 Director/Board Member - 01/01
Duncan Maskell BRD
 Director/Board Member 63 18/08/21
Paul McKenzie CEO
 Chief Executive Officer 58 01/06/19

Classe d'actions

VoteNombreFlottantAutocontrôleFlottant Total
Action A 1 483 093 257 480 846 726 ( 99,53 %) 0 99,53 %

Actionnaires

NomActions%Valorisation
State Street Global Advisors Trust Co.
1,107 %
5 349 487 1,107 % 961 M $
Colonial First State Investments Ltd.
0,9797 %
4 734 581 0,9797 % 851 M $
Commonwealth Superannuation Corp. (Investment Management)
0,6784 %
3 278 217 0,6784 % 589 M $
Netwealth Investments Ltd.
0,5316 %
2 568 812 0,5316 % 462 M $
Australian Foundation Investment Co. Ltd. (Invt Mgmt)
0,5030 %
2 431 000 0,5030 % 437 M $
BetaShares Capital Ltd.
0,3390 %
1 638 376 0,3390 % 294 M $
AMP Capital Investors Ltd.
0,2738 %
1 322 973 0,2738 % 238 M $
Argo Investments Ltd. (Investment Management)
0,2594 %
1 253 509 0,2594 % 225 M $
Russell Investment Management Ltd.
0,2531 %
1 223 105 0,2531 % 220 M $
State Street Global Advisors Ltd.
0,2172 %
1 049 591 0,2172 % 189 M $
NomActions%Valorisation
Boston Common Asset Management LLC
0,004533 %
43 811 0,004533 % 4 M $
Domini Impact Investments LLC
0,003321 %
32 100 0,003321 % 3 M $
Yousif Capital Management LLC
0,001734 %
16 760 0,001734 % 2 M $
RhumbLine Advisers LP
0,001626 %
15 712 0,001626 % 1 M $
SkyView Investment Advisors LLC
0,000829 %
8 015 0,000829 % 725 269 $
Budapest Fund Management Co. Ltd.
0,000507 %
4 901 0,000507 % 443 487 $
SVB Wealth LLC
0,000459 %
4 436 0,000459 % 401 409 $
GAMMA Investing LLC
0,000171 %
1 652 0,000171 % 149 488 $
Ametos Invest GmbH
0,000124 %
1 200 0,000124 % 108 587 $
ORG Partners LLC
0,000032 %
305 0,000032 % 27 599 $

Participations

NomActions%Valorisation
CARA THERAPEUTICS, INC.
13,53%
 7 396 770 13,53% 5 177 739 $

Coordonnées société

CSL Ltd.

655 Elizabeth Street

3000, Melbourne

+61 3 9389 1911

http://www.csl.com.au
Adresse CSL Limited(CSLLY)

Sociétés du groupe

NomCatégorie et Secteur
CSL Behring Lengnau AG
CSL Behring GmbH
Logo CSL Behring GmbH

CSL Behring GmbH

Pharmaceuticals: MajorHealth Technology

Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey.

Pharmaceuticals: Major
CSL Behring UK Ltd.
Logo CSL Behring UK Ltd.

CSL Behring UK Ltd.

Pharmaceuticals: MajorHealth Technology

Part of CSL Ltd., CSL Behring UK Ltd. is a company that manufactures and supplies plasma therapies. The company is based in Haywards Heath, UK. The British company was founded in 1916 by Emil von Behring.

Pharmaceuticals: Major
CSL Plasma GmbH
Logo CSL Plasma GmbH

CSL Plasma GmbH

Medical/Nursing ServicesHealth Services

CSL Plasma GmbH provides plasma collection and donation services. It specializes in the collection, testing, and management of plasma taken from blood donors. It focuses on the use of plasma as a key ingredient for products crucial to treating patients suffering from hemophilia, shock or trauma, immune deficiencies, and other blood disorders. It operates through its testing laboratories, collection facilities, and logistics centers. The company is headquartered in Marburg, Germany.

Medical/Nursing Services
CSL Finance GmbH
Logo CSL Finance GmbH

CSL Finance GmbH

Financial ConglomeratesFinance

Part of CSL Ltd., CSL Finance GmbH is a German company that provides investment services. The company is based in Marburg, Germany. The CEOs are Antje Michel, Dieter Engstfeld, John Andrew Goodman Levy. The company was founded in 2014.

Financial Conglomerates
CSL Behring Recombinant Facility AG
Logo CSL Behring Recombinant Facility AG

CSL Behring Recombinant Facility AG

BiotechnologyHealth Technology

Part of CSL Ltd., CSL Behring Recombinant Facility AG is a Swiss biotherapeutics company that develops and delivers innovative therapies to improve patients' lives. The company is based in Bern, Switzerland and has a manufacturing site there. The company's portfolio includes a wide range of recombinant and plasma-derived products.

Biotechnology
CSL Behring LLC
Logo CSL Behring LLC

CSL Behring LLC

BiotechnologyHealth Technology

CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.

Biotechnology
CSL Behring AG
Logo CSL Behring AG

CSL Behring AG

BiotechnologyHealth Technology

Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The company is based in Bern, Switzerland.

Biotechnology
CSL Behring Beteiligungs- und Verwaltungs GmbH & Co. KG
Logo CSL Behring Beteiligungs- und Verwaltungs GmbH & Co. KG

CSL Behring Beteiligungs- und Verwaltungs GmbH & Co. KG

Pharmaceuticals: MajorHealth Technology

Part of CSL Ltd., CSL Behring Beteiligungs- und Verwaltungs GmbH & Co. KG is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Marburg, Germany. The company was founded in 2004. The CEO is Craig Shelanskey.

Pharmaceuticals: Major

Secteur

Santé
Recherche pharmaceutique et médicale
Produits pharmaceutiques
Produits pharmaceutiques
Biopharmacies

Ventes par activité

Ventes par région

Notations pour CSL Limited

Note Trading
Note Investissement
ESG Refinitiv
Plus de notations

Consensus des Analystes

Vente
Consensus
Achat
Recommandation moyenne
ACCUMULER
Nombre d'Analystes
16
Dernier Cours de Cloture
187,2 USD
Objectif de cours Moyen
202,3 USD
Ecart / Objectif Moyen
+8,06%
Consensus

Révisions de BNA

Révisions des Estimations

Bénéfices trimestriels - Taux de surprise

Agenda de la société

Secteur Biopharmacies

Varia. 1 janv. Capi.
SAMSUNG BIOLOGICS CO.,LTD. Action Samsung Biologics Co.,Ltd.
+3,68% 41,43 Md
BIOGEN INC. Action Biogen Inc.
-10,90% 33,49 Md
BIOMARIN PHARMACEUTICAL INC. Action BioMarin Pharmaceutical Inc.
-19,56% 14,62 Md
INCYTE CORPORATION Action Incyte Corporation
-9,06% 12,77 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Action Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11,34% 11,58 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Action Chongqing Zhifei Biological Products Co., Ltd.
-43,53% 11,35 Md
SWEDISH ORPHAN BIOVITRUM AB Action Swedish Orphan Biovitrum AB
+3,75% 8,97 Md
INNOVENT BIOLOGICS, INC. Action Innovent Biologics, Inc.
-6,32% 8,3 Md
INTRA-CELLULAR THERAPIES, INC. Action Intra-Cellular Therapies, Inc.
-9,24% 7,02 Md
Biopharmacies
  1. Bourse
  2. Actions
  3. Action CSL
  4. Action CSLLY
  5. Société CSL Limited